Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000–2002
- 7 November 2012
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 132 (10), 2404-2412
- https://doi.org/10.1002/ijc.27895
Abstract
Few studies have addressed longer‐term survival for breast cancer in European women. We have made predictions of 10‐year survival for European women diagnosed with breast cancer in 2000–2002. Data for 114,312 adult women (15–99 years) diagnosed with a first primary malignant cancer of the breast during 2000–2002 were collected in the EUROCARE‐4 study from 24 population‐based cancer registries in 14 European countries. We estimated relative survival at 1, 5, and 10 years after diagnosis for women who were alive at some point during 2000–2002, using the period approach. We also estimated 10‐year survival conditional on survival to 1 and 5 years after diagnosis. Ten‐year survival exceeded 70% in most regions, but was only 54% in Eastern Europe, with the highest value in Northern Europe (about 75%). Ten‐year survival conditional on survival for 1 year was 2–6% higher than 10‐year survival in all European regions, and geographic differences were smaller. Ten‐year survival for women who survived at least 5 years was 88% overall, with the lowest figure in Eastern Europe (79%) and the highest in the UK (91%). Women aged 50–69 years had higher overall survival than older and younger women (79%). Six cancer registries had adequate information on stage at diagnosis; in these jurisdictions, 10‐year survival was 89% for local, 62% for regional and 10% for metastatic disease. Data on stage are not collected routinely or consistently, yet these data are essential for meaningful comparison of population‐based survival, which provides vital information for improving breast cancer control.Keywords
This publication has 30 references indexed in Scilit:
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry dataThe Lancet, 2011
- Up-to-date estimates of breast cancer survival for the years 2000–2004 in 11 European countries: The role of screening and a comparison with data from the United StatesEuropean Journal of Cancer, 2010
- Variation in ‘standard care’ for breast cancer across Europe: A EUROCARE-3 high resolution studyEuropean Journal of Cancer, 2010
- Adjuvant Chemotherapy in Older Women with Early-Stage Breast CancerNew England Journal of Medicine, 2009
- The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysisEuropean Journal of Cancer, 2009
- EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentaryEuropean Journal Of Cancer, 2009
- Survival trends in European cancer patients diagnosed from 1988 to 1999European Journal Of Cancer, 2009
- Long-term survival expectations of cancer patients in Europe in 2000–2002European Journal of Cancer, 2009
- Standard cancer patient population for age standardising survival ratiosEuropean Journal Of Cancer, 2004
- Period analysis for ‘up-to-date’ cancer survival dataEuropean Journal Of Cancer, 2004